Novel VEGFR‐2 Kinase Inhibitors as Anticancer Agents: A Review Focusing on SAR and Molecular Docking Studies (2016–2021)
Year: 2023
Type: review
Source: Chemistry & Biodiversity
Institution: Indo Soviet Friendship College of Pharmacy
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W4318754167
